Cargando…
Financing Pull Mechanisms for Antibiotic-Related Innovation: Opportunities for Europe
Antibiotic innovation is in serious jeopardy as companies continue to abandon the market due to a lack of profitability. Novel antibiotics must be used sparingly to hinder the spread of resistance, but small companies cannot survive on revenues that do not cover operational costs. When these compani...
Autores principales: | Årdal, Christine, Lacotte, Yohann, Ploy, Marie-Cécile |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643740/ https://www.ncbi.nlm.nih.gov/pubmed/32060511 http://dx.doi.org/10.1093/cid/ciaa153 |
Ejemplares similares
-
National Facilitators and Barriers to the Implementation of Incentives for Antibiotic Access and Innovation
por: Årdal, Christine, et al.
Publicado: (2021) -
Infection prevention and control research priorities: what do we need to combat healthcare-associated infections and antimicrobial resistance? Results of a narrative literature review and survey analysis
por: Lacotte, Yohann, et al.
Publicado: (2020) -
Supply chain transparency and the availability of essential medicines
por: Årdal, Christine, et al.
Publicado: (2021) -
Health financing reforms in the quest for universal health coverage: Challenges and opportunities in the context of Nepal
por: Pandey, Achyut R
Publicado: (2023) -
Public Health in an Era of Personal Health Records: Opportunities for Innovation and New Partnerships
por: Bonander, Jason, et al.
Publicado: (2010)